| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,740 |
2,348 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
650 |
589 |
$49K |
| 92587 |
|
915 |
876 |
$44K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
509 |
497 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,417 |
1,369 |
$34K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,170 |
1,088 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
290 |
274 |
$23K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
35 |
35 |
$23K |
| 82465 |
|
805 |
790 |
$18K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
260 |
249 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
156 |
141 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
91 |
91 |
$15K |
| 82947 |
|
781 |
768 |
$14K |
| 90461 |
|
242 |
232 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
594 |
564 |
$7K |
| 87486 |
|
53 |
53 |
$6K |
| 87581 |
|
53 |
53 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
39 |
39 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
70 |
68 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
74 |
69 |
$4K |
| 96127 |
|
1,140 |
1,104 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
42 |
41 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
26 |
24 |
$2K |
| 85027 |
|
53 |
52 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
20 |
18 |
$1K |
| 92552 |
|
88 |
88 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32 |
29 |
$1K |
| 87428 |
|
14 |
14 |
$731.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
50 |
44 |
$442.22 |
| 99173 |
|
134 |
132 |
$288.05 |
| 90686 |
|
288 |
151 |
$2.88 |
| 3078F |
|
73 |
63 |
$0.28 |
| 1036F |
|
27 |
25 |
$0.13 |